findmyKOL

John Hrom, MD

Basic profile

Hattiesburg Clinic

ORCIDNone on fileNPI
RegionHattiesburg, MS · SoutheastSpecialtyHematology / OncologyFocusOncology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

John Hrom is an Oncology physician affiliated with Hattiesburg Clinic. OpenAlex indexes 26 publications with 425 citations (h-index 8).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
26publications

Distinct works indexed by OpenAlex.

425citations

Total citations across indexed works.

8h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
68companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

301 S 28th Ave
Hattiesburg, MS 394017233

Telephone

601-288-8282

Provider last certified this registry record 3 Aug 2020.

View the NPPES registry record

Industry payments

68 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    50.1%
    PD-1 inhibitor19%
    Nivolumab76%Pembrolizumab24%
    Part B, office-administered14 patients
    Nucleoside Metabolic Inhibitor11.1%
    Azacitidine93%Fluorouracil5%Gemcitabine hydrochloride3%
    Part B, office-administered20 patients

    + 12 more classes in this area

  • Blood & clotting

    26.5%
    Iron, parenteral preparations26.4%
    Ferric carboxymaltose100%
    Part B, office-administered48 patients
    Factor Xa inhibitor0%
    Xarelto53%Eliquis47%
    Part D14 patients

    + 2 more classes in this area

  • Metabolism & gastrointestinal

    11.6%
    Other antiemetics9.3%
    Fosaprepitant100%
    Part B, office-administered34 patients
    Serotonin-3 Receptor Antagonist2.1%
    Palonosetron hcl81%Ondansetron hydrochloride16%Ondansetron Hcl2%Ondansetron Odt1%
    Part D + Part B87 patients

    + 9 more classes in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”